{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/whitlow-staphylococcal-herpetic/management/herpetic-whitlow/","result":{"pageContext":{"chapter":{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow","depth":2,"htmlHeader":"<!-- begin field 9f7b9e73-2310-4d08-84c1-901f2274f036 --><h2>Scenario: Herpetic whitlow</h2><!-- end field 9f7b9e73-2310-4d08-84c1-901f2274f036 -->","summary":"Covers the management of herpetic whitlow, including when to consider prescribing antiviral drugs.","htmlStringContent":"<!-- begin item a0fcc4f6-5d2e-467c-a606-154d4a6b8303 --><!-- begin field f1822d73-61fe-4ac1-9b46-acbd00883a78 --><p>From age 1 month onwards.</p><!-- end field f1822d73-61fe-4ac1-9b46-acbd00883a78 --><!-- end item a0fcc4f6-5d2e-467c-a606-154d4a6b8303 -->","topic":{"id":"ac1c1826-f21a-5abd-8e92-1e2db8ea28ea","topicId":"f989f159-ab30-4d16-b9df-b534a9fd4192","topicName":"Whitlow (staphylococcal and herpetic)","slug":"whitlow-staphylococcal-herpetic","lastRevised":"Last revised in January 2021","chapters":[{"id":"8442fc1d-a788-50ac-a15a-9c2c91e8589b","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"895f3b40-8720-5843-8910-fe1b288857a8","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"7e4ec3c7-b080-5717-b1c3-0003acba46e5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"7c70fe97-728d-5bc4-94c2-1996b37ee0f9","slug":"changes","fullItemName":"Changes"},{"id":"4889bd92-0b32-558d-8390-80d27fbcce73","slug":"update","fullItemName":"Update"}]},{"id":"1a79ca57-c8cc-5044-ac68-5d220bab1460","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"684fde23-e839-56ff-8b7f-8e6863b2c42d","slug":"goals","fullItemName":"Goals"},{"id":"97b35971-df6d-5ecb-a631-dfcf580e1fa9","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"12181a78-1b8d-58b4-884a-8930d15cf654","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"521ae353-eea7-5e2f-bd0e-b292540b72eb","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"87054726-2905-5ac0-b369-92e5fd68a177","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"2b6dffce-588f-532a-9776-7e3ff32005ee","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"2d957194-aa56-5cb7-98aa-cb3d8f988743","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f0191f08-fb2e-5c5b-957c-8a190d5b4539","slug":"definition","fullItemName":"Definition"},{"id":"b8b2a1f1-fbc7-5b8f-a5c4-c0e9409d566f","slug":"causes","fullItemName":"Causes"},{"id":"c7287d38-e377-5d65-9c4f-3201369e0213","slug":"prevalence","fullItemName":"Prevalence"},{"id":"adc749af-b4d0-50c9-9996-b470b8f76613","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"d632b72f-6e73-58ee-9d8d-21b6101f6394","slug":"prognosis","fullItemName":"Prognosis"},{"id":"faed0075-1878-5f17-abc9-9316eaa064e7","slug":"complications","fullItemName":"Complications"}]},{"id":"96e4a200-e348-5fab-89e2-f0ba789b7b72","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"910097a7-71be-5c13-949e-0be7c045df35","slug":"diagnosis-of-whitlow","fullItemName":"Diagnosis of whitlow"},{"id":"6f468174-fafe-579c-90f9-500f22e70e17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","fullItemName":"Management","slug":"management","subChapters":[{"id":"ac7fabf7-d7b7-5fb2-a0a6-1d28e040e2c8","slug":"staphylococcal-whitlow","fullItemName":"Scenario: Staphylococcal whitlow"},{"id":"bde8ed40-6fd8-505e-86bb-d75eac34743f","slug":"herpetic-whitlow","fullItemName":"Scenario: Herpetic whitlow"}]},{"id":"5d7afad5-ae43-5c2e-8ecf-6df00603ca01","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"ae3b006b-c4df-5e15-aee8-5ac6c019923f","slug":"aciclovir","fullItemName":"Aciclovir"},{"id":"46185de6-35ef-5e34-a1fd-e0d1463c538e","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"2a50e932-9f92-5a94-a8e5-aab1ee400b9d","slug":"erythromycin","fullItemName":"Erythromycin"},{"id":"0ad07f56-519a-59d6-90bc-6b6d6081e6ab","slug":"flucloxacillin","fullItemName":"Flucloxacillin"}]},{"id":"98ea0d83-9b18-58b4-aa73-7a50d72e15ba","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4dd77db6-a4e1-5304-8a06-196e7628f612","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"0191f79d-0e03-554c-b0bd-4b592d452f4a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3e95c155-472c-52d0-9098-a797cec2ad27","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f39c5716-7472-576a-be8f-7d705a0dc4dd","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"73c24405-a40a-51ba-ac01-8dd957f7c657","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7005b3b9-63e2-5222-840e-73155dac338e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"18dd81bb-78d7-57f1-9fc9-24aa775b3c9d","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"8ac8a269-e748-5e7e-9b74-8fb5661d1ae5","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"b37f4053-f8a8-575b-b522-06f6fdc1dc1a","slug":"management-of-herpetic-whitlow","fullItemName":"Management of herpetic whitlow","depth":3,"htmlHeader":"<!-- begin field 91fd7c09-8f3c-4294-980a-6eea7e5479ea --><h3>How should I manage a person with herpetic whitlow?</h3><!-- end field 91fd7c09-8f3c-4294-980a-6eea7e5479ea -->","summary":null,"htmlStringContent":"<!-- begin item e91c1383-6bed-4f21-ba7e-1935eb089f47 --><!-- begin field f18a5701-c9b3-4f05-bb27-6c88fb5870ce --><ul><li><strong>Wear protective gloves </strong>when touching a person with active symptoms of herpes, such as an open, fluid-filled blister.</li><li><strong>Consider prescribing an antiviral drug</strong> if the person presents soon after the onset of symptoms (for example within 48 hours). Aciclovir is recommended first line. For more information, see <a class=\"topic-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/prescribing-information/\">Prescribing information</a>.<ul><li>Antiviral drugs can be used to treat recurrent episodes if they are initiated within 48 hours of onset of symptoms.</li></ul></li><li><strong>Incision and drainage</strong><strong> of a herpetic lesion is <em>not</em> recommended.</strong></li><li><strong>Consider taking a swab for:</strong><ul><li>Virological culture if the diagnosis is uncertain, the whitlow does not resolve with treatment or is recurrent, or the person is immunocompromised.</li><li>Bacterial culture if secondary bacterial infection is suspected.</li></ul></li><li><strong>Advise the person</strong> (where appropriate) to:<ul><li>Take paracetamol or ibuprofen as required for pain relief. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a>.</li><li>Avoid touching the infected area.</li><li>Ensure that the infected finger is covered with a clean, dry dressing to prevent transmission.</li><li>Avoid touching other parts of their body with the affected finger, especially the eyes. They should avoid wearing contact lenses (instead wear glasses) until the infection has healed.</li><li>Discourage affected children from sucking their thumb.</li></ul></li><li><strong>Offer written information</strong>. Patient information on <a href=\"https://www.nhs.uk/conditions/herpetic-whitlow/\" data-hyperlink-id=\"585853bb-5126-4218-b105-aa5600a59ee6\">herpetic whitlow</a> is available from the NHS.</li><li><strong>Inform the person that recurrence is common,</strong> but the initial infection is usually the most severe.<ul><li>Offer HIV testing if the lesion is particularly extensive. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hiv-infection-aids/\">HIV infection and AIDS</a>.</li></ul></li><li>Where appropriate, manage the underlying cause of the herpetic whitlow. For more information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-genital/\">Herpes simplex - genital</a> and <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-oral/\">Herpes simplex - oral</a>.</li></ul><!-- end field f18a5701-c9b3-4f05-bb27-6c88fb5870ce --><!-- end item e91c1383-6bed-4f21-ba7e-1935eb089f47 -->","subChapters":[{"id":"6ce0ef95-b82b-53d4-a8c9-5c9fa0d1a453","slug":"basis-for-recommendation-004","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 046e7f7c-7039-4ccc-8cbe-bccba1580641 --><h4>Basis for recommendation</h4><!-- end field 046e7f7c-7039-4ccc-8cbe-bccba1580641 -->","summary":null,"htmlStringContent":"<!-- begin item 0046718e-26fc-40c4-8477-be034b0ac141 --><!-- begin field fedc11e6-af2d-441b-a734-9e0cb3d4ab28 --><h5>Antiviral drugs</h5><ul><li>This recommendation is based on expert opinion in review articles. <ul><li>Treatment within the first 48 hours of symptom onset with antiviral medications, such as aciclovir, may shorten the course of the condition [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Warbrick-Smith and Smith, 2013</a>].</li></ul></li><li>Aciclovir is licensed for the treatment of non-genital herpes simplex [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">ABPI, 2015a</a>]. There is extensive experience with its use, and it is inexpensive compared with other oral antiviral drugs [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>].</li></ul><h5>Doses of aciclovir</h5><ul><li>This information is based on the British National Formulary (BNF) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">BNF 71, 2016</a>] and the manufacturer's Summary of Product Characteristics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">ABPI, 2015a</a>].</li></ul><h5>Incision and drainage</h5><ul><li>This information is based on expert opinion in review articles. Herpetic whitlow is self limiting and usually resolves in 2–3 weeks. Incision and drainage is unnecessary, as it may cause viraemia and lead to secondary bacterial infection [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Warbrick-Smith and Smith, 2013</a>].</li></ul><h5>Taking swabs</h5><ul><li>These recommendations are based on the expert opinion of previous reviewers of this CKS topic, and what CKS considers to be best clinical practice.</li></ul><h5>Self-care advice</h5><ul><li>Self-care recommendations are pragmatic and reflect expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Sanders and Garcia, 2014</a>], and what CKS considers to be good clinical practice.</li></ul><h5>Management of recurrent cases</h5><ul><li>This information is based on expert opinion in a review article [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">Clark, 2003</a>]. The herpes virus remains dormant in the nerve cells of the fingers and may be reactivated by stress or illness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/references/\">McDonald et al, 2011</a>].</li><li>The recommendation to offer HIV testing if the lesion is extensive is based on the expert opinion of previous reviewers of this CKS topic and what CKS considers to be good clinical practice.</li></ul><!-- end field fedc11e6-af2d-441b-a734-9e0cb3d4ab28 --><!-- end item 0046718e-26fc-40c4-8477-be034b0ac141 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}